Keyphrases
Fibroblast Growth Factor Receptor 1 (FGFR1)
100%
Leukemia
100%
Neutrophils
100%
MMP-8
100%
Leukemogenesis
100%
Single-cell Analysis
100%
Tumor-associated Neutrophils
100%
Leukemia Progression
42%
Poor Prognosis
28%
Myeloid-derived Suppressor Cells
28%
Single-cell RNA Sequencing (scRNA-seq)
28%
Neutrophil Subgroups
28%
Improved Survival
14%
T Cells
14%
Gene Expression
14%
Gene Expression Changes
14%
Molecular Changes
14%
Pharmacological Inhibitors
14%
Specific Genes
14%
Gene Expression Profile
14%
Mouse Model
14%
Therapeutic Approaches
14%
Neutrophil Infiltration
14%
Differential Gene Expression
14%
Matrix Metalloproteinases
14%
Matrix metalloproteinase-9 (MMP-9)
14%
Immune Parameters
14%
Cell Recruitment
14%
Precursor Cells
14%
Immune Tolerance
14%
Cellular Changes
14%
Unique Genes
14%
Cancer Progression
14%
Gene Signature
14%
In Vitro Migration
14%
Cancer Prognosis
14%
Ilomastat
14%
TCGA Database
14%
Leukemic Mouse Model
14%
Leukemia Microenvironment
14%
MMP Genes
14%
Immunology and Microbiology
Neutrophil Granulocyte
100%
Fibroblast Growth Factor Receptor 1
100%
Single Cell Analysis
100%
Gene Expression
57%
Precursor
57%
Neutrophil
42%
Myeloid-Derived Suppressor Cell
28%
RNA Sequence
28%
T Cell
14%
Mouse
14%
Immune Tolerance
14%
Upregulation
14%
Immunocompetent Cell
14%
Gene Expression Profiling
14%
Mouse Model
14%
Neutrophil Chemotaxis
14%
Cell Composition
14%
Biochemistry, Genetics and Molecular Biology
Neutrophil Granulocyte
100%
Neutrophil Collagenase
100%
Single-Cell Analysis
100%
Precursor
57%
Gene Expression
42%
Myeloid
28%
RNA Sequence
28%
Mouse
14%
Upregulation
14%
Gene Expression Profiling
14%
T Cell
14%
Immunocompetent Cell
14%
Mouse Model
14%
Differential Gene Expression
14%
Neutrophil Chemotaxis
14%
Matrix Metalloproteinase
14%
Immunological Tolerance
14%
Cell Composition
14%
Pharmacology, Toxicology and Pharmaceutical Science
Fibroblast Growth Factor Receptor 1
100%
Neoplasm
100%
Leukemia
100%
Leukemogenesis
100%
Neutrophil Collagenase
100%
RNA-Sequencing
18%
Mouse
9%
Cancer Growth
9%
Mouse Model
9%
Matrix Metalloproteinase
9%
Syndrome
9%
Ilomastat
9%
Cancer Prognosis
9%